Journal of Healthcare Engineering

Research Article

Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca2+/Calcineurin/p-NFATc3 Pathway

Figure 6

NFATc3 phosphorylation in the nucleus of cardiomyocytes of each group.